Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-03-15
2005-03-15
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S224200, C514S230500, C514S338000, C544S048000, C544S090000, C544S333000, C546S270100, C546S271700, C548S152000, C548S217000, C548S302700
Reexamination Certificate
active
06867211
ABSTRACT:
The present invention relates to 4-pyridyl- and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy, of the formula 1:in which the variables have the meanings indicated in the description. The compounds according to the invention have immunomodulating and/or cytokine release-inhibiting action and are therefore utilizable for the treatment of disorders which are connected with a disturbance of the immune system.
REFERENCES:
patent: 3920672 (1975-11-01), Untch et al.
patent: 4536512 (1985-08-01), Biftu et al.
patent: 4539400 (1985-09-01), Fabre et al.
patent: 4546100 (1985-10-01), Fabre et al.
patent: 4560699 (1985-12-01), Muchowski et al.
patent: 4584297 (1986-04-01), Fabre et al.
patent: 4684658 (1987-08-01), Fabre et al.
patent: 4719218 (1988-01-01), Bender et al.
patent: 4873340 (1989-10-01), Muchowski et al.
patent: 5260451 (1993-11-01), Dannhardt et al.
patent: 5459152 (1995-10-01), Summers et al.
patent: 5552422 (1996-09-01), Gauthier et al.
patent: 5583148 (1996-12-01), Anderson et al.
patent: 5631122 (1997-05-01), Mihayashi et al.
patent: 5939415 (1999-08-01), Laufer et al.
patent: 5942535 (1999-08-01), Laufer et al.
patent: 5958943 (1999-09-01), Laufer et al.
patent: 198 45 446 (2000-04-01), None
patent: 100 01 166 (2001-07-01), None
patent: 0 043 858 (1982-01-01), None
patent: 0 118 321 (1984-09-01), None
patent: 0 147 317 (1985-07-01), None
patent: 0 297 987 (1989-01-01), None
patent: 0 525 823 (1993-02-01), None
patent: 0 608 133 (1994-07-01), None
patent: WO 9532970 (1995-12-01), None
patent: WO 9532971 (1995-12-01), None
patent: WO 9532972 (1995-12-01), None
patent: WO 0100332 (2001-01-01), None
patent: WO 0105792 (2001-01-01), None
patent: WO 0106792 (2001-01-01), None
Dannhardt, G., et al., “Aminomethylierung und Arylthiolierung von 6.7-Diaryl-2.3-dihydro-1H-pyrrolizinen”,Arch. Pharm., vol. 319, pp. 65-69 (1986).
Dannhardt, G., et al., “Oxidative Ringöffnung von 6.7-Diphenyl-2.3-dihydro-1H-pyrrolizin (DADHP) durch m-Chlorperbenzoesäure”,Arch. Pharm., vol. 319, pp. 231-234 (1986).
Dannhardt, G., et al., “Synthese von 3-(6.7-Diphenyl-2.3-dihydro-1H-pyrrolizin-5-yl-propionsäure”,Arch. Pharm., vol. 319, pp. 234-237 (1986).
Dannhardt, G., et al., “Synthese und Oxidation von 6.7-Diphenyl-2.3-dihydro-1H-pyrrolizin-5-yl-acetaldehyd (DADHP-5-acetaldenhyd)”,Arch. Pharm., vol. 319, pp. 500-505 (1986).
Dannhardt, G., et al., “6.7-Diarylsubstituierte 1- und 3-Pyrrolizinone (1-DAPON und 3-DAPON)”,Arch. Pharm., vol. 319, pp. 749-755 (1986).
Dannhardt, G., et al., “Natriummetaperiodat-Oxidation von 6.7-Diphenyl-2.3-dihydro-1H-pyrrolizin”,Arch. Pharm., vol. 318, pp. 661-663 (1985).
Dannhardt, G., et al., “C-5 Functionalized 6,7-Diphenyl-2,3-dihydro-1H-pyrrollizines as Inhibitors of Bovine Cyclooxygenase and 5-Lipoxygenase”,Arch. Pharm., vol. 327, pp. 509-514 (1994).
Dannhardt, G., et al., “Dihydropyrrolizinyl-substituierte 2-Aminoethanol-und Glykolsäure-Derivate”,Chemiker-Zeitung, vol. 110, pp. 124-128 (1986).
Dannhardt, G., et al., “Carbaldehyde und hydroxymethylierte Derivate Stellungsisomerer Diaryl-2,3-dihydro-1H-pyrrolizines (5,6-,5,7-und 6,7-DADHP-Derivate”,Chemiker-Zeitung, Vo. 110, pp. 267-271 (1986).
Dannhardt, G., et al., “Stellungsisomere Diaryldihydropyrrolizinyl-essigsäuren und-hydroxyethyl-Derivate”,Arch. Pharm., vol. 321, pp. 159-162 (1988).
Dannhardt, G., et al., “Stellungsisomere Diaryldihydropyrrolizinyl-ameisensäuren und-propionsäuren”,Arch. Pharm., vol. 321, pp. 545-549 (1988).
“Antiinflammatory Cyclooxygenase and 5-Lipooxygenase Inhibitor”, Drugs of the Future, vol. 20, pp. 1007-1009 (1995), Rabasseda X. et al.
Laufer, S., et al., “Synthesis and Evaluation of a Novel Series of Pyrrolizine Derivatives as Dual Cyclooxygenase-1 and 5-Lipoxygenase Inhibitors”,Arch. Pharm., vol. 330, pp. 307-312 (1997).
Laufer, S., et al., “(6,7-Diaryldihydropyrrolizin-5-yl)acetic Acids, a Novel Class of Potent Dual Inhibitors of Both Cyclooxygenase and 5-Lipoxygenase”,J. Med. Chem., vol. 37, pp. 1894-1897 (1994).
Muchowski, J., et al. “Synthesis and Antiinflammatory and Analgesic Activity of 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a] pyrrole-1-carboxylic Acids. The 6-Substituted Compounds”,J. Med. Chem., vol. 30, pp. 820-823 (1987).
Laufer Stefan
Striegel Hans-Guenter
Tollmann Karola
Tries Susanne
Merckle GmbH
Raymond Richard L.
Rothwell Figg Ernst & Manbeck
Truong Tamthom N.
LandOfFree
4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3443262